Clinical Trial Update: An Evaluation of the Medtronic Gatekeeper System in the Treatment of SUBJECTS With Gastroesophageal Reflux Disease (GERD) [NA]

View source ↗

Summary

A clinical trial evaluating the Medtronic Gatekeeper System for treating gastroesophageal reflux disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: MedtronicNeuro | Conditions: Gastroesophageal Reflux Disease | NA | Status: TERMINATED